Biology subjects

Krishnan, B.

Publications and source records attributed to Krishnan, B..

10 recordsLinked to original sources

bioRxiv2026

Repeated VU0155069 Treatment Is Associated with Region- and Pathological Stage-Specific Dendritic Spine Remodeling in Female 3xTg-AD Mice

Background: Alzheimers disease (AD) is increasingly recognized as a disorder of synaptic integrity in which changes in dendritic spine abundance and morphology accompany progressive cognitive dysfunction. Phospholipase D1 (PLD1), a regulator of membrane trafficking and cytoskeletal signaling, is aberrantly elevated in AD-related pathological states (ADRD). Previous studies from our lab demonstrated that repeated VU0155069 treatment promotes functional resilience in female 3xTg-AD mice, including improvements in novel-object recognition, fear-conditioning performance, hippocampal LTP, later-stage LTP and LTD, selected neuropathological outcomes, and most importantly, CA1 spine integrity. Objective: To determine how this previously demonstrated functional resilience is represented structurally across cortical, hippocampal, and amygdalar circuits at earlier and later stages of AD-like pathology. Methods: Female 3xTg-AD mice received vehicle or VU0155069 at 1 mg/kg intraperitoneally every other day for one month beginning at 5 or 11 months of age, with Golgi-Cox analysis at 6 or 12 months, respectively. Age-matched vehicle-treated 3xTg-AD littermates served as the primary comparator for evaluating the structural response to pharmacological attenuation of disease-associated PLD1 signaling. Results: Auditory and visual cortical fields showed selective changes in spine-subtype distribution and morphometry. Hippocampal cornu ammonis (CA)2, CA3, and dentate gyrus (DG) exhibited distinct patterns involving spine abundance, density, and geometry, whereas the central, lateral, and basolateral amygdalar nuclei showed nucleus- and stage-dependent remodeling. Across the multiregional dataset, recurring responses comprised spine-subtype redistribution, changes in spine abundance, and morphometric remodeling rather than uniform structural rescue. Conclusions: VU0155069 engages circuit- and pathological stage-specific forms of dendritic spine remodeling across distributed recognition- and associative-memory networks.

neuroscience↗

bioRxiv2026

A Toxic Tau-PFKFB3 Circuit Reduces F2,6BP Levels and Drives Neurodegeneration

Alzheimers disease (AD) and related dementias are progressive neurodegenerative disorders manifested by aggregation of Tau and Amyloid beta (A{beta}). Emerging evidence suggests that metabolic dysregulation contributes to AD pathogenesis, yet how metabolic alterations interface with neuronal integrity remains unclear. Here, we identify dysfunction in PFKFB3-F2,6BP (fructose-2,6-bisphosphate) metabolic axis as a key feature of AD. We show that pathological Tau aggregates aberrantly sequester PFKFB3, limiting its activity and resulting in F2,6BP depletion. F2,6BP exerts protective effects through multiple convergent mechanisms: (i) direct activation of polynucleotide kinase 3-phosphatase (PNKP) to facilitate DNA strand break repair; (ii) transcriptional upregulation of the protein phosphatase 2A catalytic subunit (PP2CA) to limit Tau phosphorylation; (iii) stabilization of PFKFB3 to diminish its sequestration into aggregates; and (iv) direct inhibition of Tau aggregation. These findings establish F2,6BP as a central node linking metabolic regulation to both genomic stability and proteostasis in AD. Importantly, exogenous F2,6BP supplementation rescues multiple pathological features across diverse model systems, including induced neuronal cell lines (iN), primary neurons, organotypic hippocampal slice cultures, and in a Drosophila model of AD. These findings redefine F2,6BP as a metabolite that directly coordinates genome maintenance and proteostasis in neurons. Overall, this study identifies the PFKFB3-F2,6BP axis as a central driver of AD pathogenesis and a promising therapeutic target. HighlightsO_LITau aggregates sequester PFKFB3 depletes neuronal F2,6BP C_LIO_LIF2,6BP links metabolism to DNA repair and Tau proteostasis C_LIO_LIF2,6BP activates PNKP and upregulates PP2A to counter Tau pathology C_LIO_LIF2,6BP supplementation rescues AD phenotypes across models C_LI

neuroscience↗

bioRxiv2026

Exofection as a Therapeutic Modality: Restoring P-gp Activity via Trophoblast-Derived EV in Neuroinflammatory Disorders

BackgroundP-glycoprotein (P-gp/ABCB1) is a key efflux transporter that maintains barrier integrity by clearing xenobiotics and toxic metabolites. At the feto-maternal interface, trophoblast-derived extracellular vesicles (CTC-EVs) naturally and transiently transfer functional P-gp to maternal decidual cells, restoring lost and or reduced P-gp function (exofection) to sustain pregnancy homeostasis. A similar loss of P-gp at the blood brain barrier (BBB) contributes to impaired amyloid-{beta} (A{beta}) clearance and neuroinflammation in Alzheimers disease. We investigated whether CTC-EV-mediated exofection could restore P-gp function in human brain endothelial cells (hBECs) and enhance A{beta} clearance under inflammatory and neurodegenerative conditions. MethodsCTC-EVs were isolated and characterized by nanoparticle tracking analysis and western blotting for P-gp and EV markers. Transcriptomic profiling of CTC-EVs identified enrichment of transporter-related genes, including solute carriers and ABC transporters, along with inflammatory mediators. Network analysis revealed coordinated modules linking EV cargo to transporter regulation, endocytosis/trafficking pathways, and inflammatory remodeling processes converging on BBB efflux activity. hBECs were exposed to LPS (500 ng/mL, 48 h) with or without CTC-EVs. P-gp expression was assessed by immunofluorescence (mean fluorescence intensity, MFI) and western blotting, while functional efflux was measured using Calcein-AM assays. A{beta} oligomer transport was evaluated using a transwell hBEC model. In vivo, 3xTg-AD mice received intravenous CTC-EVs (1x10L/day for 5 days), followed by assessment of P-gp expression, A{beta} burden, and neuroinflammatory markers. Pharmacokinetic studies in P-gp knockout mice were conducted to confirm functional transporter recovery. ResultsLPS exposure significantly reduced P-gp expression in hBECs (41.3% decrease in MFI, p=0.0084), which was restored by CTC-EVs (46.7% increase vs. LPS, p=0.0121). Exofection increased P-gp by a 2.1-fold following EV treatment as determined by western blot. Functional assays demonstrated enhanced efflux, with a 38.5% reduction in intracellular Calcein fluorescence (p<0.001). Network-informed mechanisms supported coordinated regulation of transporter and trafficking pathways. CTC-EVs improved A{beta} transport across inflamed hBEC monolayers. In vivo, EV-treated 3xTg-AD mice exhibited increased P-gp expression in the frontal cortex (38.6%) and hippocampus (42.1%), reduced A{beta} plaque burden (27.9%), and decreased inflammatory markers (IL-1{beta} and TNF-, p<0.05). In P-gp knockout mice, EVs reduced brain drug accumulation by 22.4% (p=0.032), confirming restoration of transporter function. ConclusionCTC derived EVs are natural carriers of functional transporter proteins and restore efflux capacity in compromised endothelial barriers. Integration of transcriptomic and network analyses highlights coordinated regulation of transporter, trafficking, and inflammatory pathways underlying exofection. This reproductive biology inspired strategy offers a promising therapeutic approach for enhancing A{beta} clearance and mitigating neuroinflammation in Alzheimers disease.

pharmacology and toxicology↗

bioRxiv2026

Exploring the PLD1-tau interaction in Frontotemporal Dementia.

SummaryFrontotemporal dementia (FTD), a leading cause of young-onset dementia, is characterized by progressive behavioral and cognitive decline associated with frontotemporal cortical atrophy. Nearly 40% of cases exhibit tauopathy, yet the molecular drivers of tau aggregation leading to synaptic dysfunction remain poorly understood. Here, we investigated whether Phospholipase D1 (PLD1, a lipid signaling enzyme), implicated in Alzheimers disease (AD), and amyotrophic lateral sclerosis (ALS), contributes to tau pathology dependent synaptic deficits in FTD. Postmortem temporal (BA38) and frontal (BA9) cortices from clinically diagnosed FTD and age-matched control subjects were analyzed using fluorescence-assisted single synaptosome long-term potentiation (FASS-LTP), immunofluorescence, proximity ligation assays (PLA), and PLD1-interactome proteomics. FASS-LTP revealed markedly reduced glutamatergic potentiation in BA38 and BA9 crude synaptoneurosomes from FTD brains compared to controls. Western blotting demonstrated elevated PLD1 expression in both crude synaptoneurosomal and cytosolic fractions from FTD subjects in BA38, but not BA9. Bielschowsky staining confirmed increased Pick body burden in FTD temporal cortex. Immunofluorescence and PLA showed robust PLD1 co-localization with total tau (HT7), hyperphosphorylated tau (AT8), and acetylated tau oligomers (TOMA2), indicating a strong spatial association between PLD1 and pathological tau species. PLD1 also exhibited enhanced co-localization with astrocytic GFAP and synaptic markers (PSD95, Nrx1{beta}), suggesting compartmentalized involvement in glial and synaptic remodeling. Proteomic profiling of PLD1-associated complexes revealed compartment-specific alterations with cytosolic fractions enriched for metabolic enzymes, stress-response proteins, and GFAP, while crude synaptoneurosomal fractions showed depletion of presynaptic scaffolds, vesicle-trafficking regulators, and proteostasis components. Cross-compartment integration indicated that over one-third of proteins were redistributed from synapses to cytosol, consistent with trafficking and degradative impairments. Gene Ontology analysis highlighted lipid metabolism, astrocyte activation, and proteasome dysfunction as dominant pathways. Collectively, these findings identify PLD1 as a critical mediator of synaptic dysfunction and tau pathology in FTD, acting through astroglial activation and disrupting synaptic proteostasis. This study provides the human clinical relevance towards PLD1 attenuation as a therapeutic target for FTD and related tauopathies to mitigate tau-driven neurodegeneration and restore synaptic integrity.

neuroscience↗

bioRxiv2025

PLD1-Dependent Regulation of Synaptic Integrity: Implications for Cognitive Resilience and Alzheimer's Disease Pathogenesis

Dysregulation of Phospholipase D1 (PLD1) has been implicated in the progression of neurodegenerative diseases, including Alzheimers Disease (AD). This study investigated PLD1 signaling in synaptic integrity and cognition during aging and in a late-onset AD mouse model, hypothesizing differential effects of PLD1 modulation on synaptic vulnerability. AAV2-mediated gene transfer was employed to overexpress (PLD1 OXP) or attenuate (PLD1 ATT) PLD1 in aged wild-type (WT) and 3xTg-AD mice. To validate these constructs, differentiated PC12 cells were utilized. Within these cells, a model of post-mitotic neurons, PLD1 OXP exhibited a notable reduction in both the average neurite length and the percentage of neurite-bearing cells. This suggests that elevated PLD1 activity exerts a significant influence on neurite outgrowth. Conversely, PLD1 ATT did not inhibit neurite formation, indicating it is not detrimental at the cellular level. These cellular findings paralleled in vivo observations - electrophysiological studies revealed PLD1 OXP impaired long-term potentiation (LTP) and synaptic transmission, particularly in aged WT mice, whereas PLD1 ATT improved synaptic function in 3xTg-AD mice. Behaviorally, PLD1 ATT enhanced spatial working memory and reduced anxiety-like behavior, notably in 3xTg-AD mice. These results highlight that tight PLD1 regulation is vital for maintaining synaptic integrity and cognitive resilience. Thus, PLD1 attenuation may serve as an important complement to immunotherapeutic approaches by strengthening synaptic resilience in neurodysfunctional states, including AD and related dementia (ADRD).

neuroscience↗

bioRxiv2025

Visual landmark coding and dynamic coupling with path integration circuits in area 29e of the rodent parahippocampal cortex

External landmarks anchor internal spatial representations. The neural mechanisms underlying this process and the sources of landmark signals remain unknown. We recorded neurons across five parahippocampal regions while rats navigated in a virtual reality apparatus, inducing conflict between self-motion and landmark cues. Area 29e, a parahippocampal field putatively homologous to primate area prostriata, maintained firing coupled to landmarks even when other regions decoupled from the landmarks. This decoupling was preceded by a decline of gamma-band influence from 29e to MEC and a concomitant decline of theta-modulated feedback from MEC to 29e. Area 29e also displayed weak theta modulation, strong gamma rhythmicity, strong egocentric head-direction tuning, and enhanced landmark contrast sensitivity. These findings provide strong evidence that 29e serves as a specialized visuospatial hub that provides landmark signals for anchoring parahippocampal spatial representations to the external world.

neuroscience↗

bioRxiv2024

Electroretinograms as a functional readout of neuronal integrity in neurodegeneration models of Drosophila melanogaster

Drosophila melanogaster serves as a powerful model for studying neurodegenerative diseases, often employing the GAL4-UAS system for targeted gene expression. Electroretinograms (ERGs) provide a robust in vivo functional readout of neuronal integrity and are increasingly used to assess disease progression and therapeutic interventions in these models. However, the genetic background upon which these models are built, particularly the widely used w1118 white-eyed mutant, can significantly influence baseline ERG characteristics. This study systematically characterizes ERG responses in wild-type Canton S (CS), w1118, and a w1118line carrying a UAS-hPLD1 construct (which includes a mini-white gene). We demonstrate profound differences in ERG amplitudes, waveforms, and responses to varying light stimuli (intensity and duration) between these genotypes, as well as significant sex-specific variations. Notably, w1118 flies exhibit markedly larger ERG amplitudes compared to CS, while the hPLD1 line shows partial compensation. We also introduce a novel quadrant-based analysis of the receptor potential, revealing distinct "fingerprints" for each genotype. These findings underscore that the w1118 background is not electrophysiologically neutral and can intrinsically alter neuronal responses. This has critical implications for interpreting ERG data from neurodegeneration models, as these background effects could mask or mimic disease-related changes. Researchers must consider these baseline differences and potential sex-specific effects to accurately attribute observed ERG phenotypes to the gene or condition under investigation. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=88 SRC="FIGDIR/small/626125v2_ufig1.gif" ALT="Figure 1"> View larger version (20K): org.highwire.dtl.DTLVardef@1b655f0org.highwire.dtl.DTLVardef@1c412e7org.highwire.dtl.DTLVardef@1b52fe3org.highwire.dtl.DTLVardef@5af680_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIERG profiles differ significantly between CS, w1118, and w1118; UAS-hPLD1 flies. C_LIO_LIThe w1118 background, common in GAL4-UAS studies, exhibits distinct ERG features. C_LIO_LISex-specific differences in ERG responses are prominent and genotype-dependent. C_LIO_LIUAS-hPLD1 insertion (with mini-white) partially alters the w1118 ERG phenotype. C_LIO_LIResults caution the interpretation of ERG data in w1118 neurodegeneration models. C_LI

neuroscience↗

bioRxiv2023

Circulating exosomes from Alzheimer's disease suppress VE-cadherin expression and induce barrier dysfunction in recipient brain microvascular endothelial cell

BackgroundBlood-brain barrier (BBB) breakdown is a component of the progression and pathology of Alzheimers disease (AD). BBB dysfunction is primarily caused by reduced or disorganized tight junction or adherens junction proteins of brain microvascular endothelial cell (BMEC). While there is growing evidence of tight junction disruption in BMECs in AD, the functional role of adherens junctions during BBB dysfunction in AD remains unknown. Exosomes secreted from senescent cells have unique characteristics and contribute to modulating the phenotype of recipient cells. However, it remains unknown if and how these exosomes cause BMEC dysfunction in AD. ObjectivesThis study aimed to investigate the potential roles of AD circulating exosomes and their RNA cargos in brain endothelial dysfunction in AD. MethodsWe isolated exosomes from sera of five cases of AD compared with age- and sex-matched cognitively normal controls using size-exclusion chromatography technology. We validated the qualities and particle sizes of isolated exosomes with nanoparticle tracking analysis and atomic force microscopy. We measured the biomechanical natures of the endothelial barrier of BMECs, the lateral binding forces between live BMECs, using fluidic force miscopy. We visualized the paracellular expressions of the key adherens junction protein VE-cadherin in BMEC cultures and a 3D BBB model that employs primary human BMECs and pericytes with immunostaining and evaluated them using confocal microscopy. We also examined the VE-cadherin signal in brain tissues from five cases of AD and five age- and sex-matched cognitively normal controls. ResultsWe found that circulating exosomes from AD patients suppress the paracellular expression levels of VE-cadherin and impair the barrier function of recipient BMECs. Immunostaining analysis showed that AD circulating exosomes damage VE-cadherin integrity in a 3D model of microvascular tubule formation. We found that circulating exosomes in AD weaken the BBB depending on the RNA cargos. In parallel, we observed that microvascular VE-cadherin expression is diminished in AD brains compared to normal controls. ConclusionUsing in vitro and ex vivo models, our study illustrates that circulating exosomes from AD patients play a significant role in mediating the damage effect on adherens junction of recipient BMEC of the BBB in an exosomal RNA-dependent manner. This suggests a novel mechanism of peripheral senescent exosomes for AD risk.

neuroscience↗

bioRxiv2022

Exosomally targeting microRNA23a ameliorates microvascular endothelial barrier dysfunction following rickettsial infection

Spotted fever group rickettsioses caused by Rickettsia (R) are devastating human infections, which mainly target microvascular endothelial cells (EC) and can induce lethal EC barrier dysfunction in the brain and lungs. Our previous evidence reveals that exosomes (Exos) derived from rickettsial-infected ECs, namely R-ECExos, can induce disruption of the tight junctional (TJ) protein ZO-1 and barrier dysfunction of human normal recipient brain microvascular endothelial cells (BMECs). However, the underlying mechanism remains elusive. Given that we have observed that microRNA23a (miR23a), a negative regulator of endothelial ZO-1 mRNA, is selectively sorted into R-ECExos, the aim of the present study was to characterize the potential functional role of exosomal miR23a delivered by R-ECExos in normal recipient BMECs. We demonstrated that EC-derived Exos (ECExos) have the capacity to deliver oligonucleotide RNAs to normal recipient BMECs in an RNase-abundant environment. miR23a in ECExos impairs normal recipient BMEC barrier function, directly targeting TJ protein ZO-1 mRNAs. In separate studies using a traditional in vitro model and a novel single living-cell biomechanical assay, our group demonstrated that miR23a anti-sense oligonucleotide-enriched ECExos ameliorate R-ECExo-provoked recipient BMEC dysfunction in association with stabilization of ZO-1 in a dose-dependent manner. These results suggest that Exo-based therapy could potentially prove to be a promising strategy to improve vascular barrier function during bacterial infection and concomitant inflammation.

cell biology↗

bioRxiv2018

Mechanistic insights from replica exchange molecular dynamics simulations into mutation induced disordered-to-ordered transition in Hahellin, a βγ-crystallin

Intrinsically disordered proteins (IDPs) form a special category because they lack a unique well-folded 3D structure under physiological conditions. They play crucial role in cell signaling, regulatory functions and responsible for several diseases. Although, they are abundant in nature, only a small fraction of it has been characterized till date. Such proteins adopt a range of conformations and can undergo transformation from disordered-to-ordered state or vice-versa upon binding to ligand. Insights of such conformational transition is perplexing in several cases. In the present study, we characterized disordered as well as ordered states and the factors contributing the transitions through a mutational study by employing replica exchange molecular dynamics simulation on a {beta}{gamma}-crystallin. Most of the proteins within this superfamily are inherently ordered. However, Hahellin, although a member of {beta}{gamma}-crystallin, it is intrinsically disordered in its apo-form which takes a well-ordered {beta}{gamma}-crystallin fold upon binding to Ca2+. It is intriguing that the mutation at the 5th position of the canonical motif to Arg increases the domain stability in several ordered microbial {beta}{gamma}-crystallins with concomitant loss in Ca2+ binding affinity. We carried out similar Ser to Arg mutations at 5th position of the canonical motif for the first time in an intrinsically disordered protein to understand the mechanistic insights of conformational transition. Our study revealed that newly formed ionic and hydrogen bonding interactions at the canonical Ca2+ binding sites play crucial role in transforming the disordered conformation into ordered {beta}{gamma}-crystallin.\n\nAuthor summaryIntrinsically disordered proteins lack a unique ordered 3D structure under physiological condition. Although, they are abundant in nature, only a small fraction of these proteins has been characterized till date due to adaptation of multiple conformations and methodological limitation. {beta}{gamma}-crystallins are inherently ordered, however recently a small number of proteins within this superfamily have been identified as intrinsically disordered protein. Hahellin is one such protein which is intrinsically disordered in its apo-form but takes a well-ordered {beta}{gamma}-crystallin fold upon binding to Ca2+. In the present study, we decipher the underlying mechanism of disordered-to-ordered transition in Hahellin by mutations, employing replica exchange molecular dynamics simulations. Earlier experimental studies reported an increase in stabilization of the ordered {beta}{gamma}-crystallion upon mutation to Arg at 5th position of the canonical Ca2+ binding motifs, N/D-N/D-X1-X2-S/T-S. We performed similar Ser to Arg mutation in an intrinsically disordered Hahellin to get the mechanistic insights of the conformational transition in the absence of Ca2+. Our study revealed that several newly formed ionic and hydrogen bonding interactions contributed by the mutant residues are responsible for both intra- and inter-motif rigidification, resulting in overall stability of {beta}{gamma}-crystallin domain.

biophysics↗